NASDAQ:EIGR - Eiger BioPharmaceuticals, Inc.
$10.87
 $0.10
+0.97%
1:05PM EDT
2019-07-22
Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of orphan diseases. Its pipeline includes Sarasar (lonafarnib) for hepatitis delta virus (HDV), exendin (9-39) for severe hypoglycemia, and Bestatin (ubenimex) for pulmonary arterial hypertension (PAH) and lymphedema. Lonafarnib is an orally active inhibitor of farnesyl transferase that inhibits the prenylation step of HDV replication inside liver cells and blocks the ability of the virus to multiply. It is conducting over three Phase II clinical trials, which include LOnafarnib With and without Ritonavir (LOWR) HDV-2 (Ankara, Turkey), LOWR HDV-3 (NIH) and LOWR HDV-4 (Hannover, Germany). Exendin is in Phase II clinical studies for the treatment of hypoglycemia associated with bariatric surgery. Ubenimex is in Phase II clinical studies for the treatment of PAH and lymphedema. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  EIGR     avg for
industry  
  avg for
sector  
42 stocks weight:  22. 83   217. 37   399. 45  
42 stocks rank:  3. 08 K 1. 27 K 716. 99  
# analyst opinions:  6. 00   13. 21   13. 71  
mean recommendation:  1. 00   2. 10   2. 04  

quick ratio:  7. 92   5. 49   1. 88  
current ratio:  8. 16   5. 87   2. 36  

target price low:  22. 00   83. 44   114. 90  
target price avg:  11. 67   106. 20   137. 90  
target price high:  19. 42   132. 30   158. 97  
1-yr high:  14. 96   111. 86   142. 57  
last close:  10. 77   86. 79   125. 44  
50-day avg:  10. 84   86. 68   122. 63  
200-day avg:  11. 82   89. 22   121. 38  
1-yr low:  8. 63   69. 78   100. 51  
volume:  91. 38 K 2. 62 M 3. 43 M
50-day avg volume:  270. 04 K 3. 20 M 4. 16 M
200-day avg volume:  176. 01 K 2. 99 M 4. 75 M

1-day return:  -3. 84 % -1. 30 % -0. 99 %
this week return:  -4. 61 % 0. 45 % -0. 20 %
12-wk return:  -2. 97 % 0. 94 % 4. 84 %
52-wk return:  5. 66 % -1. 30 % 10. 55 %

enterprise value (EV):  209. 29 M 45. 10 B 122. 38 B
market cap:  263. 17 M 38. 96 B 108. 40 B
EBITDA:  -59. 41 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -3. 52   5. 38   11. 93  
total debt:  31. 91 M 10. 90 B 17. 48 B
debt/equity:  62. 81   57. 18   120. 05  
net income (common):  -60. 75 M 2. 07 B 4. 05 B

shares outstanding:  19. 26 M 538. 09 M 1. 24 B
shares:  13. 24 M 548. 00 M 1. 22 B
shares short:  572. 95 K 10. 98 M 11. 87 M
shares short prior month:  230. 92 K 9. 32 M 12. 05 M
short ratio:  1. 51   5. 60   3. 34  
short % of float:  3. 47 % 6. 48 % 2. 64 %
total cash/share:  3. 51   10. 98   9. 19  
total cash:  85. 79 M 5. 93 B 6. 10 B
free cash flow:  -29. 48 M 2. 92 B 4. 55 B
operating cash flow:  -52. 98 M 3. 80 B 5. 78 B

book value:  2. 64   13. 35   27. 45  
price/book:  4. 08   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -3. 83   2. 10   4. 23  
forward EPS:  -2. 29   3. 45   7. 10  
P/E:  -2. 81   1. 90   32. 10  
forward P/E:  -4. 70   6. 46   15. 47  
PE/G:  0. 17   0. 70   -0. 54  
growth:  -16. 15 % 265. 63 % 79. 11 %
earnings high:  -0. 67   0. 89   1. 68  
earnings avg:  -0. 74   0. 70   1. 57  
earnings low:  -0. 84   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -58. 38 % -2. 34 % 5. 28 %
return on equity:  -185. 38 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  1. 25   1. 27   0. 91  
sharpe (1yr):  0. 27   0. 16   0. 77  

held % insiders:  1. 88 % 6. 06 % 3. 29 %
held % institutions:  81. 31 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : EIGR
.    113.456 =       113.456 :: --> INITIAL WEIGHT <--
.    - 3.828 =       109.628 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.043 =       223.979 :: P/E factor
.    x 1.548 =       346.689 :: PE/G factor
.    x 1.473 =       510.669 :: beta factor
.    x 0.733 =         374.4 :: sharpe factor
.    x 2.609 =       976.641 :: current ratio factor
.     x 1.07 =       1044.78 :: quick ratio factor
.    x 1.289 =      1347.018 :: short ratio factor
.     x 1.05 =      1414.123 :: price-to-book factor
.    x 1.379 =      1950.018 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      4135.584 :: sector+industry 1-year gains factor
.    x 1.009 =      4174.574 :: industry 12-weeks return factor
.    x 1.308 =      5459.878 :: industry 2-weeks return factor
.    x 0.999 =      5456.472 :: company one-year gains+dividend factor
.    x 3.246 =     17712.656 :: company 13 weeks' performance factor
.    x 1.098 =     19449.114 :: 5-day avg > 50-day avg
.    x 0.979 =     19036.458 :: "drift" penalty 1 days ago
.    x 0.977 =     18593.678 :: "drift" penalty 5 days ago
.    / 1.962 =      9476.501 :: overall "drift" factor
.     x 0.73 =      6914.548 :: largest single-day jump factor
.    x 0.156 =      1078.713 :: low price factor
.    x 1.081 =      1166.393 :: notable returns + performance factor
.    x 3.046 =       3553.38 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.768 =      2729.622 :: forward EPS factor
.    x 0.916 =      2499.678 :: forward P/E factor
.    x 1.185 =        2961.4 :: industry recommendation factor
.     x 3.42 =     10126.859 :: company recommendation factor
.    x 1.003 =     10154.864 :: factor historical industry gain for week 29
.   x 10.568 =    107320.834 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          18.1 :: reduced for readability
.    + 4.364 =        22.464 :: add/subtract for investor sentiment
.    + 0.369 =        22.833 :: earnings report in 18 days
.                               --> FINAL WEIGHT <--
.                     22.833 :: FINAL WEIGHT for NASDAQ:EIGR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org